BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11995776)

  • 1. The use of SSRIs in depressive disorders specific to women.
    Altshuler LL
    J Clin Psychiatry; 2002; 63 Suppl 7():3-8. PubMed ID: 11995776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical treatment of depression during pregnancy or breast feeding].
    Terp IM
    Ugeskr Laeger; 2007 Jun; 169(23):2233; author reply 2233, 2235. PubMed ID: 17607851
    [No Abstract]   [Full Text] [Related]  

  • 3. The Expert Consensus Guideline Series. Treatment of depression in women.
    Altshuler LL; Cohen LS; Moline ML; Kahn DA; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Mar; (Spec No):1-107. PubMed ID: 11500997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical treatment of depression during pregnancy and breastfeeding].
    Nielsen RE; Stage KB; Christensen PM; Mortensen S; Andersen LL; Damkier P
    Ugeskr Laeger; 2007 Apr; 169(16):1442-4. PubMed ID: 17484841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression in women: diagnostic and treatment considerations.
    Bhatia SC; Bhatia SK
    Am Fam Physician; 1999 Jul; 60(1):225-34, 239-40. PubMed ID: 10414640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation and management of depression in women across the life span.
    Kornstein SG
    J Clin Psychiatry; 2001; 62 Suppl 24():11-7. PubMed ID: 11676428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors in pregnancy and lactation.
    Gupta S; Masand PS; Rangwani S
    Obstet Gynecol Surv; 1998 Dec; 53(12):733-6. PubMed ID: 9870234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding.
    Gentile S
    Arch Womens Ment Health; 2006 May; 9(3):158-9. PubMed ID: 16683078
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapies for psychiatric symptoms in women: possibilities and cautions.
    Cohen LS; Rosenbaum JF
    Harv Rev Psychiatry; 1994; 1(6):353-5. PubMed ID: 9384871
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors in the treatment of mood disorders in primary care: depression and premenstrual syndrome.
    Allan TR; Goldstein L
    Conn Med; 1996 Apr; 60(4):215-9. PubMed ID: 8776125
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of SSRI antidepressants on popular notions of women's depressive illness.
    Metzl JM; Angel J
    Soc Sci Med; 2004 Feb; 58(3):577-84. PubMed ID: 14652053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care.
    Appleby L; Koren G; Sharp D
    Br J Gen Pract; 1999 Oct; 49(447):780-2. PubMed ID: 10885079
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and endothelial function in women.
    Hantsoo L; Czarkowski KA; Child J; Howes C; Epperson CN
    J Womens Health (Larchmt); 2014 Jul; 23(7):613-8. PubMed ID: 24886268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety.
    Macdougall M; Steiner M
    Expert Opin Drug Saf; 2003 Mar; 2(2):161-6. PubMed ID: 12904116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants in the treatment of premenstrual dysphoric disorder.
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 14():4-10; discussion 11-3. PubMed ID: 9418742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of antidepressant use in pregnant and nursing women.
    Lamberg L
    JAMA; 1999 Jul; 282(3):222-3. PubMed ID: 10422977
    [No Abstract]   [Full Text] [Related]  

  • 20. Sertraline for premenstrual dysphoric disorder.
    Cohen LS
    JAMA; 1998 Feb; 279(5):357-8. PubMed ID: 9459467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.